Literature DB >> 5043143

Tumor immunity in vitro: destruction of a mouse ascites tumor through a cycling pathway.

G Berke, K A Sullivan, D B Amos.   

Abstract

Lymphocytes in peritoneal exudate from BALB/(c) mice immunized against ascites leukemia EL4 are uniquely efficient at destroying (51)chromiumlabeled EL4 cells in vitro. The lytic process depends upon the number of lymphocyte-tumor cell interactions. Efector lymphocytes are not inactivated as a result of lethal contact but can interact repeatedly with tumor cells.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5043143     DOI： 10.1126/science.177.4047.433

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  12 in total

Review 1.  Perforin and its role in T lymphocyte-mediated cytolysis.

Authors:  B Lowin; O Krähenbühl; C Müller; M Dupuis; J Tschopp
Journal:  Experientia       Date:  1992-10-15

2.  Influenza peptide-induced self-lysis and down-regulation of cloned cytotoxic T cells.

Authors:  R M Pemberton; D C Wraith; B A Askonas
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

Review 3.  Mechanisms and functions for the duration of intercellular contacts made by lymphocytes.

Authors:  Daniel M Davis
Journal:  Nat Rev Immunol       Date:  2009-07-17       Impact factor: 53.106

4.  Resistance of cytotoxic T lymphocytes to lysis by a clone of cytotoxic T lymphocytes.

Authors:  D M Kranz; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Large agranular lymphocytes: early non-specific effector cells in allograft rejection in the mouse.

Authors:  C D Gregory; M E Atkinson
Journal:  Immunology       Date:  1984-10       Impact factor: 7.397

Review 6.  Intravital imaging of CD8+ T cell function in cancer.

Authors:  Thorsten R Mempel; Christian A Bauer
Journal:  Clin Exp Metastasis       Date:  2008-07-30       Impact factor: 5.150

7.  Activation of human NKCC by moderate exercise: increased frequency of NK cells with enhanced capability of effector--target lytic interactions.

Authors:  S Targan; L Britvan; F Dorey
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

8.  Switch from perforin-expressing to perforin-deficient CD8(+) T cells accounts for two distinct types of effector cytotoxic T lymphocytes in vivo.

Authors:  Avihai Meiraz; Orit Gal Garber; Shaul Harari; David Hassin; Gideon Berke
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

9.  Rejection of ascites tumor allografts. II. A pathway for cell-mediated tumor destruction in vitro by peritoneal exudate lymphoid cells.

Authors:  G Berke; K A Sullivan; B Amos
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

10.  Resistance of cytotoxic T lymphocytes to the lytic effects of their toxic granules.

Authors:  C R Verret; A A Firmenich; D M Kranz; H N Eisen
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.